10-53822169-T-G
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_033056.4(PCDH15):c.5557A>C(p.Met1853Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000376 in 1,614,040 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1853T) has been classified as Uncertain significance.
Frequency
Consequence
NM_033056.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH15 | NM_033056.4 | c.5557A>C | p.Met1853Leu | missense_variant | 33/33 | ENST00000320301.11 | |
PCDH15 | NM_001384140.1 | c.4368-1939A>C | intron_variant | ENST00000644397.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.5557A>C | p.Met1853Leu | missense_variant | 33/33 | 1 | NM_033056.4 | ||
PCDH15 | ENST00000644397.2 | c.4368-1939A>C | intron_variant | NM_001384140.1 |
Frequencies
GnomAD3 genomes ? AF: 0.000322 AC: 49AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000672 AC: 169AN: 251396Hom.: 1 AF XY: 0.000913 AC XY: 124AN XY: 135848
GnomAD4 exome AF: 0.000382 AC: 558AN: 1461816Hom.: 6 Cov.: 32 AF XY: 0.000514 AC XY: 374AN XY: 727210
GnomAD4 genome ? AF: 0.000322 AC: 49AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74426
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 30, 2021 | This variant is associated with the following publications: (PMID: 30245029, 21569298, 18727382, 15028842, 12711741, 25262649, 20672374) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | PCDH15: BP4 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 25, 2016 | p.Met1853Leu in exon 33 of PCDH15: This variant is not expected to have clinica l significance because it has been identified in 0.4% (61/16510) of South Asian chromosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145903555). Although this variant has been previously reported in compound heterozygosity with a pathogenic variant i n one Ashkenazi Jewish individual with Usher syndrome, it was also detected in 0 .32% (9/2836) of control chromosomes from various Ashkenazi and non-Ashkenazi Je wish populations. In addition, computational prediction tools and conservation a nalyses suggest that this variant may not impact the protein. In summary, due t o the frequency of this variant in the general population, it is likely benign. - |
PCDH15-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Usher syndrome type 1F Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 27, 2020 | - - |
Usher syndrome type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 24, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at